Congressional Testimony 1999

-

November

11/09/1999 Investigational New Drugs
William Raub, Ph.D., before the House Committee on Government Reform, Subcommittee on National Security, Veterans Affairs, and International Relations

-

10/28/1999 Year 2000 (Y2K) Update
William K. Hubbard, before the House Committee on Veterans' Affairs, Subcommittee on Oversight and Investigations
10/21/1999 Y2K
William K. Hubbard, before the House Committte on Commerce, Subcommittee on Health and Environment, and Subcommittee on Oversight and Investigations
10/21/1999 FDAMA
Jane E. Henney, M.D., before the Senate Committee on Health, Education, Labor and Pensions
10/21/1999 Genetically Engineered Foods
James H. Maryanski Ph.D., before the House Committee on Science, Subcommittee on Basic Research
10/12/1999 Vaccine Licensing
Kathryn C. Zoon, Ph.D., before the House Committee on Government Reform
10/07/1999 Bioengineered Food
James H. Maryanski Ph.D., before the Senate Committee on Agriculture, Nutrition and Forestry

-

08/04/1999 Protecting the Nations's Food Supply
Jane E. Henney, M.D., before the Senate Committee on Governmental Affairs, Subcommittee on Oversight of Government Managemenet, Restructuring and the District of Columbia

-

07/30/1999 Drug Sales Over the Internet
Janet Woodcock, M.D., before the House Committee on Commerce, Subcommittee on Oversight and Investigations
07/21/1999 FDA's Vaccine Adverse Event Reporting System
Susan S. Ellenberg, Ph.D., before the House Committee on Government Reform, Subcommittee on National Security, Veterans Affairs, and International Relations
07/01/1999 Oversight of Egg Safety
Morris E. Potter, D.V.M., before the Senate Committee on Governmental Affairs, Subcommittee on Government Management, Restructuring, and the District of Columbia

-

05/27/1999 Vaccine Adverse Event Reporting System
Joseph A. Levitt, before the House Committee on Government Reform
05/25/1999 Year 2000 Date Issue as it Relates to Medical Devices
William K. Hubbard, before the House Committee on Commerce, Subcommittee on Oversight and Investigations, and Subcommittee on Health and Environment
05/18/1999 Vaccine Adverse Event Reporting System (VAERS)
Susan S. Ellenberg, Ph.D., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy and Human Resources

-

04/29/1999 Safety and Efficacy of the Anthrax Vaccine
Kathryn C. Zoon, Ph.D., before the House Committee on Government Reform, Subcommittee on National Security, Veterans Affairs and International Relations
04/20/1999 Year 2000 date and Medical Devices
Thomas Shope, Ph.D., before the Senate Committee on Veterans' Affairs
04/15/1999 Year 2000 Date Issue as it Relates to Medical Devices and Pharmaceuticals
William K. Hubbard, before the House Committee on Veterans' Affairs

-

03/25/1999 Implementation of the Dietary Supplement Health and Education Act (DSHEA) of 1994
Jane E. Henney, M.D., before the House Committee of Government Reform
03/25/1999 Regulation of Natural Rubber Latex Gloves
Elizabeth D. Jacobson, Ph.D., before the House Committee on Education and Workforce, Subcommittee on Oversight and Investigations
03/16/1999 Food Safety Accomplishments for Fiscal Year 1998
Jane E. Henney, M.D., before the Committee on Appropriations, Subcommittee on Agriculture, Rural Development, and Related Agencies
03/11/1999 Scheduling of Drugs Under the Controlled Substances Act
Nicholas Reuter, M.P.H., before the House Committee on Commerce, Subcommittee on Oversight and Investigations

-